AIM ImmunoTech Inc. — Director's Dealing 2019

Sep 20, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2019-09-16

Reporting Person: LINTAL ELLEN M (CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	364	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to buy Common Stock	$9.68	2028-11-14	Common Stock (23)		Direct

Footnotes

F1: This option has been awarded by the Board of Directors.